Plasma trough concentrations of darunavir/ritonavir and raltegravir in older patients with HIV-1 infection

Long-Term Mortality in HIV-Infected Individuals 50 Years or Older

(2016) Rebecca A. Legarth et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

The pharmacokinetic profile of raltegravir-containing antiretroviral therapy in HIV-infected individuals over 60 years of age

(2015) Jaime H. Vera et al.   HIV CLINICAL TRIALS

Geriatric Syndromes in Older HIV-Infected Adults

(2015) Meredith Greene et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Future challenges for clinical care of an ageing population infected with HIV: a modelling study

(2015) Mikaela Smit et al.   LANCET INFECTIOUS DISEASES

Antiretroviral Treatment Efficacy and Safety in Older HIV-Infected Adults

(2015) Jacqueline Jourjy et al.   PHARMACOTHERAPY

Short Communication: Aging Not Gender Is Associated with High Atazanavir Plasma Concentrations in Asian HIV-Infected Patients

(2013) Anchalee Avihingsanon et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Pharmacokinetics of two common antiretroviral regimens in older HIV-infected patients: a pilot study

(2013) JB Dumond et al.   HIV MEDICINE

Switching to darunavir/ritonavir 800/100 mg once-daily containing regimen maintains virological control in fully suppressed pre-treated patients infected with HIV-1

(2012) Jade Ghosn et al.   JOURNAL OF MEDICAL VIROLOGY

Age-Related Changes in Plasma Concentrations of the HIV Protease Inhibitor Lopinavir

(2010) Keith W. Crawford et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Total Raltegravir Concentrations in Cerebrospinal Fluid Exceed the 50-Percent Inhibitory Concentration for Wild-Type HIV-1

(2010) D. Croteau et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Validation of a rapid and sensitive high-performance liquid chromatography–tandem mass spectrometry (HPLC–MS/MS) assay for the simultaneous determination of existing and new antiretroviral compounds

(2010) Laura Else et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Pharmacokinetics, Efficacy, and Safety of Darunavir/Ritonavir 800/100 mg Once-Daily in Treatment-Naïve and -Experienced Patients

(2009) Marta Boffito et al.   HIV CLINICAL TRIALS

Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry

(2008) R. ter Heine et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Single-Measurement Therapeutic Drug Monitoring of the HIV/AIDS Drugs Abacavir, Zidovudine, Lamivudine, Efavirenz, Nevirapine, Lopinavir and Nelfinavir

(2008) Josef Donnerer et al.   PHARMACOLOGY